Zealand Pharma A/S
ZLDPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $31,705 | $25,651 | $36,817 | $46,219 |
| - Cash | $937 | $7,244 | $776 | $480 |
| + Debt | $64 | $397 | $395 | $392 |
| Enterprise Value | $30,832 | $18,804 | $36,436 | $46,130 |
| Revenue | $50 | $9,088 | $8 | $9 |
| % Growth | -99.5% | 112,212% | -10.6% | – |
| Gross Profit | $7 | $9,088 | $8 | $9 |
| % Margin | 13.4% | 100% | 95% | 95.5% |
| EBITDA | -$353 | $8,125 | -$323 | -$277 |
| % Margin | -711.2% | 89.4% | -3,992.9% | -3,059.5% |
| Net Income | -$63 | $7,574 | -$335 | -$291 |
| % Margin | -127.9% | 83.3% | -4,144.1% | -3,213.7% |
| EPS Diluted | -0.9 | 105.61 | -4.75 | -4.64 |
| % Growth | -100.9% | 2,323.4% | -2.4% | – |
| Operating Cash Flow | -$70 | $8,519 | -$501 | -$180 |
| Capital Expenditures | -$1 | -$7 | -$9 | -$3 |
| Free Cash Flow | -$70 | $8,513 | -$510 | -$183 |